Development of a technological framework for using virus-like particles as adjuvants in prophylactic and therapeutic vaccines: demonstration of effect in animal models and humans

Gerardo Guillén, Luís Herrera, Santiago Dueñas et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2011

Cited by 0